Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 1
2015 2
2016 3
2017 7
2018 8
2019 9
2020 9
2021 12
2022 10
2023 15
2024 12
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Rifampicin drug monitoring in TB patients: new evidence for increased dosage?
Schiuma M, Colaneri M, Cattaneo D, Fusi M, Civati A, Galimberti M, Cossu MV, Gervasoni C, Dolci A, Riva A, Antinori S, Gori A, Torre A. Schiuma M, et al. Among authors: cossu mv. Int J Tuberc Lung Dis. 2025 May 25;29(5):202-206. doi: 10.5588/ijtld.24.0465. Int J Tuberc Lung Dis. 2025. PMID: 40281673
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.
Ciccullo A, Baldin G, Cervo A, Moschese D, Lagi F, Cossu MV, Grimaldi A, Giacomelli A, Rusconi S, Sterrantino G, Borghetti A, Antinori S, Mussini C, Di Giambenedetto S. Ciccullo A, et al. Among authors: cossu mv. J Antimicrob Chemother. 2025 Jan 3;80(1):175-177. doi: 10.1093/jac/dkae392. J Antimicrob Chemother. 2025. PMID: 39478330
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Role of multi-site sampling in the diagnosis of human Monkeypox.
Rizzo A, Mileto D, Moschese D, Candela C, Mancon A, Giacomelli A, Raccagni AR, Salari F, Cossu MV, Micheli V, Castagna A, Rizzardini G, Lombardi A, Nozza S, Gismondo MR. Rizzo A, et al. Among authors: cossu mv. J Infect. 2023 Feb;86(2):154-225. doi: 10.1016/j.jinf.2022.12.010. Epub 2022 Dec 12. J Infect. 2023. PMID: 36521564 Free PMC article. No abstract available.
Is smallpox vaccination protective against human monkeypox?
Moschese D, Farinacci D, Pozza G, Ciccullo A, Cossu MV, Giacomelli A, Borgonovo F, Mileto D, Santangelo R, Tamburrini E, Rizzardini G, Antinori S, Giambenedetto SD. Moschese D, et al. Among authors: cossu mv. J Med Virol. 2023 Jan;95(1):e28077. doi: 10.1002/jmv.28077. Epub 2022 Sep 2. J Med Virol. 2023. PMID: 35993271 No abstract available.
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025.
Moschese D, Esvan R, Fusetti C, Barchi V, Cossu MV, Giacinta A, Lazzarin S, Terracini G, Caruso F, Micheli G, Maddalena D, Del Duca G, Petri F, Frate G, Matone M, Farinacci D, Giacomelli A, Faccendini P, Visigalli D, Passacantilli S, Riva A, Antinori A, Gori A, Mazzotta V. Moschese D, et al. Among authors: cossu mv. Euro Surveill. 2025 Oct;30(39):2500739. doi: 10.2807/1560-7917.ES.2025.30.39.2500739. Euro Surveill. 2025. PMID: 41040064 Free PMC article.
95 results